Literature DB >> 26819214

[Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].

Michael Feichtinger1,2, Tina Stopp1,2, Christian Göbl3.   

Abstract

Polycystic ovarian syndrome represents the most common endocrine disease of women of reproductive age. Symptoms include metabolic, gynecologic and cosmetic features. Genetic factors seem to contribute to the disease, affecting not only women but also male relatives of patients with similar symptoms. Besides, lifestyle factors play a central role impacting clinical PCOS appearance. Following we present an overview of the syndrome, its epidemiology, metabolic and gynecological aspects, gender and genetic factors and its therapy.

Entities:  

Keywords:  Metabolism; Polycystic Ovarian Syndrome; Reproductive Medicine

Mesh:

Year:  2016        PMID: 26819214     DOI: 10.1007/s10354-016-0439-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  40 in total

Review 1.  Metformin for the treatment of the polycystic ovary syndrome.

Authors:  John E Nestler
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

Review 2.  Regulation of ovarian follicular development in primates: facts and hypotheses.

Authors:  A Gougeon
Journal:  Endocr Rev       Date:  1996-04       Impact factor: 19.871

3.  Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment.

Authors:  Li Tian; Huan Shen; Qun Lu; Robert J Norman; Jim Wang
Journal:  J Clin Endocrinol Metab       Date:  2007-01-23       Impact factor: 5.958

4.  Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.

Authors:  F Cano; J A García-Velasco; A Millet; J Remohí; C Simón; A Pellicer
Journal:  J Assist Reprod Genet       Date:  1997-05       Impact factor: 3.412

5.  Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

Authors:  R J Norman; L Masters; C R Milner; J X Wang; M J Davies
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 6.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Lisa J Moran; Marie L Misso; Robert A Wild; Robert J Norman
Journal:  Hum Reprod Update       Date:  2010-02-16       Impact factor: 15.610

7.  Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.

Authors:  R Kaushal; N Parchure; G Bano; J-C Kaski; S S Nussey
Journal:  Clin Endocrinol (Oxf)       Date:  2004-03       Impact factor: 3.478

8.  Metabolic profile in sons of women with polycystic ovary syndrome.

Authors:  Sergio E Recabarren; Rosita Smith; Rafael Rios; Manuel Maliqueo; Bárbara Echiburú; Ethel Codner; Fernando Cassorla; Pedro Rojas; Teresa Sir-Petermann
Journal:  J Clin Endocrinol Metab       Date:  2008-01-29       Impact factor: 5.958

9.  Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.

Authors:  Enrico Carmina; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2004-09       Impact factor: 7.329

10.  Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008.

Authors:  Ekwutosi M Okoroh; W Craig Hooper; Hani K Atrash; Hussain R Yusuf; Sheree L Boulet
Journal:  Am J Obstet Gynecol       Date:  2012-07-20       Impact factor: 8.661

View more
  2 in total

1.  [Not Available].

Authors:  Alexandra Kautzky-Willer
Journal:  Wien Med Wochenschr       Date:  2016-03

2.  Up-Regulation of Long Noncoding RNA SRA Promotes Cell Growth, Inhibits Cell Apoptosis, and Induces Secretion of Estradiol and Progesterone in Ovarian Granular Cells of Mice.

Authors:  Yan Li; Haixu Wang; Dangxia Zhou; Ting Shuang; Haibo Zhao; Biliang Chen
Journal:  Med Sci Monit       Date:  2018-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.